🦁
|
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
66 auth.
J. McMurray,
S. Adamopoulos,
S. Anker,
A. Auricchio,
M. Böhm,
K. Dickstein,
V. Falk,
G. Filippatos,
C. Fonseca,
M. Gómez-Sánchez,
T. Jaarsma,
L. Køber,
G. Lip,
A. Maggioni,
A. Parkhomenko,
...
B. Pieske,
B. Popescu,
P. Rønnevik,
F. Rutten,
J. Schwitter,
P. Seferovic,
J. Stȩpińska,
P. Trindade,
A. Voors,
F. Zannad,
A. Zeiher,
J. Bax,
H. Baumgartner,
C. Ceconi,
V. Dean,
C. Deaton,
R. Fagard,
C. Funck-Brentano,
D. Hasdai,
A. Hoes,
P. Kirchhof,
J. Knuuti,
P. Kolh,
T. McDonagh,
C. Moulin,
Ž. Reiner,
U. Sechtem,
P. Sirnes,
M. Tendera,
A. Torbicki,
A. Vahanian,
S. Windecker,
L. A. Bonet,
P. Avraamides,
Hisham A. Ben Lamin,
M. Brignole,
A. Coca,
Peter Cowburn,
H. Dargie,
P. Elliott,
F. Flachskampf,
Guido Francesco Guida,
S. Hardman,
B. Iung,
B. Merkely,
C. Mueller,
J. Nanas,
O. Nielsen,
S. Ørn,
J. Parissis,
P. Ponikowski
|
13 |
2012 |
13 🦁
|
🐜
|
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
24 auth.
C. Yancy,
M. Jessup,
B. Bozkurt,
J. Butler,
D. Casey,
M. Drazner,
G. Fonarow,
S. Geraci,
T. Horwich,
J. Januzzi,
...
Maryl R. Johnson,
E. Kasper,
W. Levy,
F. Masoudi,
P. Mcbride,
J. McMurray,
J. Mitchell,
Pamela N. Peterson,
B. Riegel,
F. Sam,
L. Stevenson,
W. Tang,
E. Tsai,
B. Wilkoff
|
13 |
2013 |
13 🐜
|
🦁
|
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
11 auth.
J. McMurray,
M. Packer,
Akshay S. Desai,
J. Gong,
M. Lefkowitz,
A. Rizkala,
...
J. Rouleau,
V. Shi,
S. Solomon,
K. Swedberg,
M. Zile
|
12 |
2014 |
12 🦁
|
🐜
|
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
50 auth.
P. Kirchhof,
S. Benussi,
D. Kotecha,
A. Ahlsson,
D. Atar,
B. Casadei,
M. Castellà,
H. Diener,
H. Heidbuchel,
J. Hendriks,
G. Hindricks,
A. Manolis,
J. Oldgren,
B. Popescu,
U. Schotten,
...
B. V. Van putte,
P. Vardas,
S. Agewall,
J. Camm,
G. Baron Esquivias,
W. Budts,
S. Carerj,
F. Casselman,
A. Coca,
R. de Caterina,
S. Deftereos,
D. Dobrev,
J. Ferro,
G. Filippatos,
D. Fitzsimons,
B. Gorenek,
M. Guenoun,
S. Hohnloser,
P. Kolh,
G. Lip,
A. Manolis,
J. McMurray,
P. Ponikowski,
R. Rosenhek,
F. Ruschitzka,
I. Savelieva,
Sanjay Sharma,
P. Suwalski,
J. Tamargo,
C. Taylor,
I. V. Van Gelder,
A. Voors,
S. Windecker,
J. Zamorano,
K. Zeppenfeld
|
12 |
2016 |
12 🐜
|
🦁
|
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
39 auth.
J. McMurray,
S. Solomon,
S. Inzucchi,
L. Køber,
M. Kosiborod,
F. Martinez,
P. Ponikowski,
M. Sabatine,
I. Anand,
J. Bělohlávek,
M. Böhm,
C. Chiang,
V. Chopra,
Rudolf A. de Boer,
Akshay S. Desai,
...
M. Diez,
J. Drożdż,
A. Dukát,
J. Ge,
J. Howlett,
T. Katova,
M. Kitakaze,
C. Ljungman,
B. Merkely,
J. Nicolau,
E. O’Meara,
M. Petrie,
P. N. Vinh,
M. Schou,
S. Tereshchenko,
S. Verma,
C. Held,
D. DeMets,
K. Docherty,
P. Jhund,
O. Bengtsson,
M. Sjöstrand,
A. Langkilde,
Modele O Ogunniyi
|
11 |
2019 |
11 🦁
|
🐜
|
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
24 auth.
C. Yancy,
M. Jessup,
B. Bozkurt,
J. Butler,
D. Casey,
M. Drazner,
G. Fonarow,
S. Geraci,
T. Horwich,
J. Januzzi,
...
Maryl R. Johnson,
E. Kasper,
W. Levy,
F. Masoudi,
P. Mcbride,
J. McMurray,
J. Mitchell,
Pamela N. Peterson,
B. Riegel,
F. Sam,
L. Stevenson,
W. Tang,
E. Tsai,
B. Wilkoff
|
11 |
2013 |
11 🐜
|
🐜
|
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
9 auth.
S. Yusuf,
M. Pfeffer,
K. Swedberg,
C. Granger,
P. Held,
J. McMurray,
...
E. Michelson,
B. Olofsson,
J. Östergren
|
11 |
2003 |
11 🐜
|
🐜
|
Eplerenone in patients with systolic heart failure and mild symptoms.
9 auth.
F. Zannad,
J. McMurray,
H. Krum,
D. V. van Veldhuisen,
K. Swedberg,
Harry Shi,
...
J. Vincent,
S. Pocock,
B. Pitt
|
11 |
2011 |
11 🐜
|
🐜
|
Dapagliflozin in Patients with Chronic Kidney Disease.
14 auth.
H. Heerspink,
B. Stefánsson,
R. Correa-Rotter,
G. Chertow,
T. Greene,
F. Hou,
J. Mann,
J. McMurray,
M. Lindberg,
P. Rossing,
...
C. Sjöström,
R. Toto,
A. Langkilde,
D. Wheeler
|
11 |
2020 |
11 🐜
|
🦁
|
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
9 auth.
J. McMurray,
J. Östergren,
K. Swedberg,
C. Granger,
P. Held,
E. Michelson,
...
B. Olofsson,
S. Yusuf,
M. Pfeffer
|
11 |
2003 |
11 🦁
|
🐜
|
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
16 auth.
M. Pfeffer,
B. Claggett,
R. Diaz,
K. Dickstein,
H. Gerstein,
L. Køber,
Francesca C. Lawson,
Lin Ping,
Xiaodan Wei,
E. Lewis,
...
A. Maggioni,
J. McMurray,
J. Probstfield,
M. Riddle,
S. Solomon,
J. Tardif
|
10 |
2015 |
10 🐜
|
🐜
|
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
9 auth.
M. Pfeffer,
K. Swedberg,
C. Granger,
P. Held,
J. McMurray,
E. Michelson,
...
B. Olofsson,
J. Östergren,
S. Yusuf
|
10 |
2003 |
10 🐜
|
🐜
|
Effects of dalcetrapib in patients with a recent acute coronary syndrome.
17 auth.
G. Schwartz,
A. Olsson,
M. Abt,
C. Ballantyne,
P. Barter,
J. Brumm,
B. Chaitman,
I. Holme,
D. Kallend,
Lawrence A Leiter,
...
E. Leitersdorf,
J. McMurray,
H. Mundl,
S. Nicholls,
P. Shah,
J. Tardif,
R. Wright
|
10 |
2012 |
10 🐜
|
🐜
|
Irbesartan in patients with heart failure and preserved ejection fraction.
11 auth.
B. Massie,
P. Carson,
J. McMurray,
M. Komajda,
R. McKelvie,
M. Zile,
...
S. Anderson,
M. Donovan,
E. Iverson,
C. Staiger,
A. Ptaszynska
|
10 |
2008 |
10 🐜
|
🐬
|
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
M. Vaduganathan,
O. Vardeny,
T. Michel,
J. McMurray,
M. Pfeffer,
S. Solomon
|
10 |
2020 |
10 🐬
|